Tuesday, December 16, 2025

Latest

BMO Lowers Aritzia’s Price Target, Points To Inflation Headwinds

Last week Aritzia (TSX: ATZ) reported their fiscal fourth quarter ending February 26 results. The company reported revenues of $444.32 million, an increase of 66% year over year. Retail revenues amounted to $262.35 million, for an increase of 123% year over year. eCommerce revenue also remained strong, growing 22% year over year to $181.97 million for the quarter.

Gross profits also grew substantially to $179.5 million, up 75% year over year. However, expenses also grew 66% year over year as the company could not outrun inflation, with expenses totaling out at $120.2 million. This put net income flat on a year-over-year basis at $34.23 million, or $0.29 earnings per share.

Additionally, Aritzia said that it grew its active US clients by over 100% over the fiscal year, and “strategically managed global supply chain disruptions to ensure product availability to meet demand.” They also note that they repurchased 164,200 shares under their normal course issuer bid at an average price of $54.79 for a total consideration of $9 million.

Lastly, Aritzia said it was on track to hit its $375 million fiscal first-quarter revenue guidance, and expects net revenue for the year to be $1.8 billion. They also expect gross profits to take a 1% drop while expenses will slightly grow as a percentage of revenue for the full year.

Aritzia currently has 8 analysts covering the stock with an average 12-month price target of C$62.14, or a 67% upside to the current stock price. Out of the 8 analysts, 3 have strong buy ratings, 4 have buy ratings and the last analyst has a hold rating on the stock. The street high sits at C$70, which represents a 90% upside to the current stock price.

In BMO Capital Markets’ note on the results, they reiterate their outperform rating and lower their 12-month price target from $70 to $61, saying that the fourth quarter results came in strong but guidance proves inflation is hitting the operations hard but the long-term margins should go higher.

On the results, BMO says that the company beat their adjusted EPS estimate of $0.24 with the actual results coming in at $0.34. While adjusted EBITDA was also better than their $49 million estimate. On the top-line growth, BMO says that they are glad to see the growth momentum has continued into the fiscal fourth quarter. Combined with a strong top-line guide, they believe that over the long term, e-commerce and the U.S market provide Aritzia with a margin tailwind.

Lastly, BMO says that Aritzia’s success in the U.S will be the growth engine for the company. They note that customers “are responding extremely well to Aritzia’s boutique experience, e-commerce offering, and product assortment.” This has provided Aritzia with a solid growth runway and they believe that this will be Aritzia’s segment to give the business exceptional growth.

Below you can see BMO’s updated estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Soma Gold: Q3 Earnings Impacted By Labour Strike

Thesis Gold: The Multi-Billion Dollar Lawyers-Ranch PFS

Why Canada Has So Few Projects That Can Be Built Before 2030 | Dan Wilton – First Mining

Recommended

Japan Gold Concludes Geophysical Survey At Hakuryu Project For Drill Targeting

Steadright Locks Up Goundafa Polymetallic Mine Under Binding MOU

Related News

Else Nutrition: Canaccord Drops Price Target To $5.75

On Friday, Else Nutrition (CSE: BABY) reported their fourth quarter and year end financials. The...

Monday, May 3, 2021, 11:44:00 AM

SNAP Sees Consensus Price Target To $12.47 After Q3 Results

Snap Inc (NYSE: SNAP) on Friday reported its third-quarter financial results. The company announced revenues...

Sunday, October 23, 2022, 03:20:00 PM

Canaccord Adjusts Well Health Estimates, Leaves Ratings Unchanged

This morning, Canaccord Genuity raised their estimates on WELL Health Technologies (TSX: WELL) off the...

Friday, November 13, 2020, 11:23:08 AM

Canopy Growth: Canaccord Downgrades To Hold, Raises Price Target To $32

Yesterday, Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) reported their third fiscal quarter results. They...

Wednesday, February 10, 2021, 04:12:00 PM

WeCommerce: Canaccord Drops Target To $10 After Q4 Estimate Miss

WeCommerce (TSXV: WE) reported its fourth quarter and full-year financial results on March 29th, with...

Monday, April 4, 2022, 03:56:00 PM